AKRO Overview
Upcoming Projects (AKRO)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AKRO)
-
A Third View: Investigating the Phase 2b HARMONY clinical trial results of efruxifermin (EFX) in patients with MASH.
Ticker: AKRO
Executed On: Mar 27, 2024 at 03:00 PM EDT -
A Second View: Investigating the Phase 2b HARMONY clinical trial results of efruxifermin (EFX) in patients with MASH.
Ticker: AKRO
Executed On: Mar 22, 2024 at 01:00 PM EDT -
Investigating the Phase 2b HARMONY clinical trial results of efruxifermin (EFX) in patients with MASH.
Ticker: AKRO
Executed On: Mar 21, 2024 at 05:15 PM EDT -
Discussing Akero's recent announcement of their Phase 2b SYMMETRY study results evaluating efruxifermin (EFX) in patients with compensated cirrhosis due to NASH
Tickers: AKRO, MDGL, ENTB, VKTX
Executed On: Jan 10, 2024 at 05:15 PM EST -
A Fourth Look at Efruxifermin as a therapy for nonalcoholic steatohepatitis
Ticker: AKRO
Executed On: Oct 07, 2022 at 12:00 PM EDT -
A Third Look at Efruxifermin as a therapy for nonalcoholic steatohepatitis
Ticker: AKRO
Executed On: Oct 03, 2022 at 12:00 PM EDT -
A Second Look at Efruxifermin as a therapy for nonalcoholic steatohepatitis
Ticker: AKRO
Executed On: Sep 30, 2022 at 02:00 PM EDT -
A First Look at Efruxifermin as a therapy for nonalcoholic steatohepatitis
Ticker: AKRO
Executed On: Sep 30, 2022 at 12:00 PM EDT
Upcoming & Overdue Catalysts (AKRO)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (AKRO)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
